WVE Insider Transactions — Page 2
196 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–196; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO | 2023-02-16 | Sale | 29,400.0 | $4.04 |
| Francis Chris | See Remarks | 2023-02-16 | Sale | 10,258.0 | $4.03 |
| Moran Kyle | Chief Financial Officer | 2023-02-16 | Sale | 9,729.0 | $4.04 |
| RA Capital Healthcare Fund LP | Director,TenPercentOwner | 2022-06-16 | Purchase | 9,480,052.0 | $2.15 |
| RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | 2022-06-16 | Purchase | 9,480,052.0 | $2.15 |
| Kolchinsky Peter | Director,TenPercentOwner | 2022-06-16 | Purchase | 9,480,052.0 | $2.15 |
| Shah Rajeev M. | Director,TenPercentOwner | 2022-06-16 | Purchase | 9,480,052.0 | $2.15 |
| Vargeese Chandra | See Remarks | 2022-05-05 | Sale | 16,714.0 | $1.72 |
| BOLNO PAUL | President and CEO | 2022-05-05 | Sale | 33,501.0 | $1.72 |
| Moran Kyle | Chief Financial Officer | 2022-05-05 | Sale | 5,021.0 | $1.72 |
| Panzara Michael A. | See Remarks | 2022-05-05 | Sale | 16,714.0 | $1.72 |
| Francis Chris | See Remarks | 2022-05-05 | Sale | 10,867.0 | $1.72 |
| Moran Kyle | Chief Financial Officer | 2022-02-16 | Sale | 9,204.0 | $2.31 |
| Francis Chris | See Remarks | 2022-02-16 | Sale | 10,123.0 | $2.31 |
| Vargeese Chandra | Chief Technology Officer | 2022-02-16 | Sale | 10,603.0 | $2.32 |
| BOLNO PAUL | President and CEO | 2022-02-16 | Sale | 33,150.0 | $2.32 |
| Panzara Michael A. | See Remarks | 2022-02-16 | Sale | 10,603.0 | $2.31 |
| Francis Chris | See Remarks | 2021-02-16 | Sale | 2,698.0 | $10.57 |
| BOLNO PAUL | President and CEO | 2021-02-16 | Sale | 11,205.0 | $10.57 |
| Panzara Michael A. | See Remarks | 2021-02-16 | Sale | 2,929.0 | $10.57 |
| Vargeese Chandra | Chief Technology Officer | 2021-02-16 | Sale | 3,145.0 | $10.57 |
| Moran Kyle | Chief Financial Officer | 2021-02-16 | Sale | 1,722.0 | $10.57 |
| BOLNO PAUL | President and CEO | 2020-09-15 | Sale | 100,000.0 | $15.0 |
| BOLNO PAUL | President and CEO | 2020-08-25 | Sale | 25,000.0 | $12.0 |
| BOLNO PAUL | President and CEO | 2020-07-02 | Sale | 95,921.0 | $10.27 |
| BOLNO PAUL | President and CEO | 2020-07-02 | Sale | 4,079.0 | $10.91 |
| BOLNO PAUL | President and CEO | 2020-07-02 | Sale | 43,068.0 | $10.26 |
| BOLNO PAUL | President and CEO | 2020-07-02 | Sale | 4,509.0 | $10.82 |
| Panzara Michael A. | Chief Medical Officer | 2020-02-18 | Sale | 2,981.0 | $7.85 |
| BOLNO PAUL | President and CEO | 2020-02-18 | Sale | 11,451.0 | $7.85 |
| Francis Chris | See Remarks | 2020-02-18 | Sale | 2,708.0 | $7.85 |
| Vargeese Chandra | Senior VP, Drug Discovery | 2020-02-18 | Sale | 3,188.0 | $7.85 |
| Gaiero David G | Interim CFO | 2020-02-03 | Sale | 651.0 | $7.0 |
| Vargeese Chandra | Senior VP, Drug Discovery | 2019-12-03 | Sale | 6,000.0 | $35.0 |
| Verdine Gregory L. | Director | 2019-11-20 | Sale | 2,609.0 | $32.74 |
| Verdine Gregory L. | Director | 2019-11-20 | Sale | 3,400.0 | $31.59 |
| Verdine Gregory L. | Director | 2019-11-20 | Sale | 24,030.0 | $30.27 |
| Panzara Michael A. | Chief Medical Officer | 2019-07-05 | Sale | 445.0 | $27.26 |
| Panzara Michael A. | Chief Medical Officer | 2019-07-05 | Sale | 2,613.0 | $26.88 |
| BOLNO PAUL | President and CEO | 2019-03-15 | Sale | 1,763.0 | $46.0 |
| BOLNO PAUL | President and CEO | 2019-03-15 | Sale | 8,237.0 | $45.22 |
| BOLNO PAUL | President and CEO | 2019-03-15 | Sale | 5,065.0 | $45.89 |
| BOLNO PAUL | President and CEO | 2019-03-15 | Sale | 34,935.0 | $45.45 |
| Panzara Michael A. | Franchise Lead, Neurology | 2019-03-11 | Sale | 7,000.0 | $48.0 |
| Regnante Keith | Chief Financial Officer | 2019-02-19 | Sale | 1,298.0 | $36.84 |
| Panzara Michael A. | Franchise Lead, Neurology | 2019-02-19 | Sale | 1,837.0 | $36.84 |
| BOLNO PAUL | President and CEO | 2019-02-19 | Sale | 119.0 | $37.47 |
| BOLNO PAUL | President and CEO | 2019-02-19 | Sale | 7,614.0 | $36.38 |
| Vargeese Chandra | Senior VP, Drug Discovery | 2019-02-19 | Sale | 2,055.0 | $36.84 |
| Francis Chris | See Remarks | 2019-02-19 | Sale | 1,709.0 | $36.84 |
| RA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | 2019-01-24 | Purchase | 263,158.0 | $38.0 |
| Kolchinsky Peter | Director,TenPercentOwner | 2019-01-24 | Purchase | 263,158.0 | $38.0 |
| Verdine Gregory L. | Director | 2018-11-14 | Sale | 4,300.0 | $39.52 |
| Verdine Gregory L. | Director | 2018-11-14 | Sale | 10,700.0 | $38.59 |
| Francis Chris | See Remarks | 2018-09-25 | Sale | 10,543.0 | $56.0 |
| Francis Chris | See Remarks | 2018-09-24 | Sale | 1,032.0 | $56.0 |
| Regnante Keith | Chief Financial Officer | 2018-09-24 | Sale | 29,500.0 | $55.0 |
| Vargeese Chandra | Senior VP, Drug Discovery | 2018-09-24 | Sale | 3,000.0 | $55.0 |
| Francis Chris | See Remarks | 2018-07-09 | Sale | 596.0 | $38.22 |
| Francis Chris | See Remarks | 2018-07-09 | Sale | 23,900.0 | $37.25 |
| Francis Chris | See Remarks | 2018-06-01 | Sale | 24,496.0 | $48.0 |
| Francis Chris | See Remarks | 2018-05-30 | Sale | 24,496.0 | $45.5 |
| BOLNO PAUL | President and CEO | 2018-05-30 | Sale | 20,250.0 | $45.0 |
| BOLNO PAUL | President and CEO | 2018-05-29 | Sale | 3,145.0 | $45.0 |
| BOLNO PAUL | President and CEO | 2018-05-25 | Sale | 8,316.0 | $45.0 |
| BOLNO PAUL | President and CEO | 2018-05-02 | Sale | 18,289.0 | $45.0 |
| Francis Chris | See Remarks | 2018-02-20 | Sale | 11,504.0 | $55.95 |
| Francis Chris | See Remarks | 2018-02-16 | Sale | 9,412.0 | $55.0 |
| Francis Chris | See Remarks | 2018-02-16 | Sale | 723.0 | $51.8 |
| BOLNO PAUL | President and CEO | 2018-02-16 | Sale | 2,200.0 | $51.62 |
| BOLNO PAUL | President and CEO | 2018-02-16 | Sale | 514.0 | $51.01 |
| Panzara Michael A. | Franchise Lead, Neurology | 2018-02-16 | Sale | 511.0 | $52.1 |
| Regnante Keith | Chief Financial Officer | 2018-02-16 | Sale | 316.0 | $51.85 |
| Vargeese Chandra | See Remarks | 2018-02-15 | Sale | 2,000.0 | $50.0 |
| Panzara Michael A. | Franchise Lead, Neurology | 2018-02-15 | Sale | 18,750.0 | $50.0 |
| Vargeese Chandra | See Remarks | 2018-01-23 | Sale | 2,000.0 | $40.0 |
| Vargeese Chandra | See Remarks | 2017-11-22 | Sale | 1,500.0 | $35.0 |
| RA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | 2017-11-14 | Purchase | 23,398.0 | $24.0 |
| Kolchinsky Peter | Director,TenPercentOwner | 2017-11-14 | Purchase | 23,398.0 | $24.0 |
| RA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | 2017-11-13 | Purchase | 400,000.0 | $23.3 |
| Kolchinsky Peter | Director,TenPercentOwner | 2017-11-13 | Purchase | 400,000.0 | $23.3 |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership | TenPercentOwner | 2017-09-18 | Sale | 6,362.0 | $24.19 |
| Tanaka Masaharu | Director,TenPercentOwner | 2017-09-18 | Sale | 6,362.0 | $24.19 |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership | TenPercentOwner | 2017-09-15 | Sale | 14,385.0 | $24.22 |
| Tanaka Masaharu | Director,TenPercentOwner | 2017-09-15 | Sale | 14,385.0 | $24.22 |
| Panzara Michael A. | Franchise Lead, Neurology | 2017-07-12 | Sale | 7,414.0 | $16.67 |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership | TenPercentOwner | 2017-03-29 | Sale | 433,825.0 | $24.91 |
| Tanaka Masaharu | Director,TenPercentOwner | 2017-03-29 | Sale | 433,825.0 | $24.91 |
| Verdine Gregory L. | Director | 2016-06-15 | Sale | 52,000.0 | $16.7 |
| RA Capital Healthcare Fund LP | Director,TenPercentOwner | 2015-11-16 | Purchase | 1,875,000.0 | $16.0 |
| RA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | 2015-11-16 | Purchase | 1,875,000.0 | $16.0 |
| Kolchinsky Peter | Director,TenPercentOwner | 2015-11-16 | Purchase | 1,875,000.0 | $16.0 |
| TAKANASHI KEN | Director,TenPercentOwner | 2015-11-16 | Purchase | 125,000.0 | $16.0 |
| Shin Nippon Biomedical Laboratories, Ltd. | TenPercentOwner | 2015-11-16 | Purchase | 125,000.0 | $16.0 |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership | TenPercentOwner | 2015-11-16 | Purchase | 76,250.0 | $16.0 |
| Tanaka Masaharu | Director,TenPercentOwner | 2015-11-16 | Purchase | 76,250.0 | $16.0 |